Recalls / Active ingredient / Verapamil Hydrochloride
Verapamil Hydrochloride
4 FDA drug recalls involving the active ingredient “Verapamil Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-07-02 | Class III | Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only, | Zydus Pharmaceuticals (USA) Inc |
| 2024-07-02 | Class III | Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per car | Zydus Pharmaceuticals (USA) Inc |
| 2023-08-14 | Class III | Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Ma | Glenmark Pharmaceuticals Inc., USA |
| 2021-03-15 | Class II | Verapamil Hydrochloride Extended-Release Tablets USP 120 mg Rx Only NDC 68462-292-01 Manufactured by: Glenmark | Cardinal Health Inc. |